Myriapod Archivi - Seite 3 von 4 - Diatech

21 07, 2020

Umberto Malapelle et. al., Predictive molecular pathology in the time of coronavirus disease

Diatech Pharmacogenetics2020-07-21T14:11:03+02:00

29 06, 2020

Marco Mammana et. al., Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis

Diatech Pharmacogenetics2020-11-03T14:34:17+01:00

16 05, 2020

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Diatech Pharmacogenetics2020-11-03T15:11:22+01:00

7 05, 2020

Elisabetta Zulato et. al., Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

Diatech Pharmacogenetics2020-11-03T15:24:44+01:00

31 07, 2019

Sergio Migliore et al., Large-scale PRNP genotyping of small ruminants using an automated high-throughput MALDI-TOF MS assay.

Diatech Pharmacogenetics2019-07-31T09:07:37+02:00

2 05, 2019

Paola Bordi et al., From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC

Diatech Pharmacogenetics2019-05-02T09:45:38+02:00

29 04, 2019

Michela Notarangelo et al., Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood

Diatech Pharmacogenetics2019-04-29T09:51:27+02:00

11 04, 2019

Enrico Mini et al., RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

Diatech Pharmacogenetics2019-04-11T11:26:55+02:00

14 02, 2019

Lorenza Rimassa et al., Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition

Diatech Pharmacogenetics2019-02-14T09:32:18+01:00

15 11, 2018

Matteo Fassan et. al, miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

Diatech Pharmacogenetics2018-11-15T14:42:45+01:00

Vorheriges 234 Nächstes